Key Highlights

● Second-quarter sales rose to $2,513 million from $2,287 million a year earlier.

● Adjusted earnings before interest and tax rose to $320 million from $275 million.

● Chemical Intermediates sales grew 39 per cent, while Fibres sales fell 11 per cent.

● Management targets 2026 cost savings of $125 million to $150 million, net of inflation.

Eastman Chemical Company (NYSE:EMN), the Kingsport-based specialty materials producer, reported second-quarter 2026 results on 30 July 2026, and the figures showed a business recovering from a soft opening to the year. Sales revenue was $2,513 million, up from $2,287 million a year earlier, with volume and mix contributing five percentage points of growth and higher selling prices four. Adjusted earnings before interest and tax rose to $320 million from $275 million, and adjusted diluted earnings per share reached $1.97 against $1.60. GAAP diluted earnings per share were $1.59 compared with $1.20. The company said adjusted EBIT margin improved by 350 basis points sequentially. For the first half, adjusted EPS of $3.06 still trailed the $3.51 reported for the same period of 2025, which puts the quarter in context: a sharp sequential improvement rather than a return to the earnings level of two years ago. Full-year 2025 adjusted EPS was $5.42, according to the annual report.

Segments: olefins strength, fibres weakness

The quarter's divergence between segments was striking. Chemical Intermediates grew sales 39 per cent, helped by a 24 per cent rise in volume and mix and a 14 per cent price gain in olefins and derivatives, with earnings lifted by wider spreads. Advanced Materials sales rose 5 per cent, though its earnings fell on lower asset utilisation and higher variable compensation. Additives and Functional Products also grew sales 5 per cent, with earnings broadly unchanged. Fibres was the weak spot: sales fell 11 per cent as volume declined 10 per cent, and earnings were hit by lower acetate tow pricing and Middle East-related logistics costs. Management's third-quarter outlook is for adjusted EPS to approach the second-quarter figure of $1.97, with Advanced Materials and Fibres expected to improve and the other two segments easing modestly. These are company projections.

Cash flow, leverage and the dividend

Cash generation is where investors will look hardest. Operating cash flow was $224 million in the quarter, against $233 million a year earlier, and $87 million for the first half. Capital expenditure was $203 million in the six months, so operating cash flow after capex was negative on our arithmetic; Eastman does not report a free cash flow figure. Net debt stood at $4,526 million at 30 June, compared with $4,221 million at the end of 2025, and cash was $691 million. Management now expects full-year operating cash flow to approach $900 million, slightly below its earlier view because of receivables, with capital expenditure of about $400 million and a release of working capital in the second half. On those guided figures, the implied surplus would be roughly $500 million before dividends. Dividends paid were $96 million in the quarter and $192 million in the half. Market data indicates a quarterly payout of about $0.84 per share, or $3.36 annualised, with cover depending on the second-half cash release being delivered.

A Recovery Still Short of Prior Peaks

Eastman's second quarter marks a clear sequential improvement, but first-half adjusted earnings per share of $3.06 still trail the $3.51 posted a year earlier and remain well below the $5.42 reported for all of fiscal 2025. The divergence between a strong Chemical Intermediates business and a weak Fibres segment, together with net debt that has climbed to $4,526 million, means the pace of the recovery will depend on raw-material costs, logistics disruption and the targeted cost savings landing as planned.